GHK-Cu enters cells bound to copper, scans DNA, and resets over 4,000 genesturning on collagen/elastin factories (types I, III, V), growth factors (VEGF for blood vessels, TGF-beta for remodeling), and antioxidants while shutting down inflammation (NF-B, TNF-alpha) and junk protein buildup (proteasome boost)
Some health plans may cover one option but not the other, or they might require prior authorization for specific uses
Indications for Switching A switch may be appropriate when a patient has reached the maximum tolerated tirzepatide dose (15 mg weekly) and plateaued below their weight target, or when GI side effects on tirzepatide are persistent despite dose reduction
Verify current pricing on official websites before enrollment